Overview
- 175 inspections across 145 sites are on record.
- 161 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
175
Sites
145
Observations
161
Career since
Feb 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Areeg Hassan El-Gharbawy, MD, DSc | 1 May 2026 | Biologics | |
| Adeyemi Gbohunmi, MD, PhD | 16 Jan 2026 | Human Drugs | |
| Children's Healthcare of Atlanta IRB | 7 Nov 2025 | Medical Devices & Rad Health | |
| Alejandro Vasquez, MD | 17 Oct 2025 | Medical Devices & Rad Health | |
| Actelion Pharmaceuticals US Inc. | 28 Oct 2024 | Human Drugs | On file |
Sites inspected
Areeg Hassan El-Gharbawy, MD, DScDurham, United States1 insp.
Adeyemi Gbohunmi, MD, PhDMansfield, United States1 insp.
Children's Healthcare of Atlanta IRBAtlanta, United States1 insp.
Alejandro Vasquez, MDHuntsville, United States1 insp.
Actelion Pharmaceuticals US Inc.Titusville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sereen G Morgan-Murray9 shared
Simone M Edmonson6 shared
Robin N Goins6 shared
Nicole M Bell5 shared
Sandra I Gaul4 shared
Koffi A Amegadje3 shared
Amanda L Evanco3 shared
Hugh M Mcclure2 shared
Stefanie R Cook2 shared
Ana C Lazo2 shared
Full investigator report
Get the verbatim findings behind Vanessa E Coulter's 161 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site